1-3 of 3
Monica Davey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors

George D. Demetri, Paolo G. Casali, Jean-Yves Blay, Margaret von Mehren, Jeffrey A. Morgan, Rossella Bertulli, Isabelle Ray-Coquard, Philippe Cassier, Monica Davey, Hossein Borghaei, Daniel Pink, Maria Debiec-Rychter, Wing Cheung, Stuart M. Bailey, Maria Luisa Veronese, Annette Reichardt, Elena Fumagalli, Peter Reichardt
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (18): 5910–5916.
https://doi.org/10.1158/1078-0432.CCR-09-0542
Published: 14 September 2009
View articletitled, A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors
Open the PDF for A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors in another window
Journal Articles

The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma

Margaret von Mehren, Philip Arlen, James Gulley, André Rogatko, Harry S. Cooper, Neal J. Meropol, R. Katharine Alpaugh, Monica Davey, Susan McLaughlin, Mary T. Beard, Kwong Y. Tsang, Jeffrey Schlom, Louis M. Weiner
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (5): 1181–1191.
Published: 01 May 2001
View articletitled, The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma
Open the PDF for The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma in another window
Journal Articles

Pilot Study of a Dual Gene Recombinant Avipox Vaccine Containing Both Carcinoembryonic Antigen (CEA) and B7.1 Transgenes in Patients with Recurrent CEA-expressing Adenocarcinomas

Margaret von Mehren, Philip Arlen, Kwong Y. Tsang, André Rogatko, Neal Meropol, Harry S. Cooper, Monica Davey, Susan McLaughlin, Jeffrey Schlom, Louis M. Weiner
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (6): 2219–2228.
Published: 01 June 2000
View articletitled, Pilot Study of a Dual Gene Recombinant Avipox Vaccine Containing Both Carcinoembryonic Antigen (CEA) and B7.1 Transgenes in Patients with Recurrent CEA-expressing Adenocarcinomas
Open the PDF for Pilot Study of a Dual Gene Recombinant Avipox Vaccine Containing Both Carcinoembryonic Antigen (CEA) and B7.1 Transgenes in Patients with Recurrent CEA-expressing Adenocarcinomas in another window